Does Teva Pharmaceutical Deserve a Place in Your 2022 Portfolio?

Published on January 12, 2022

Israel-based Teva Pharmaceutical (TEVA) is conducting trials regarding the use of opioids. But is it wise to bet on the stock now based on its sound fundamentals? Read on, let’s...

Continue reading on website
Other news

Is Marqeta a Good Software Stock to Buy Now?

January 12, 2022
Software company Marqeta (MQ) has forged several strategic partnerships since going public on June 9, 2021. So, let’s evaluate if it is wise to buy the dip in the stock...

Immigrant Business Owners Are the Key to Supercharging America's Economy

January 12, 2022
Foreign-born entrepreneurs are crucial to a robust economy, but immigration policies stand in the way.